Heterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat diet

dc.contributor.affiliationUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicasgl
dc.contributor.affiliationUniversidade de Santiago de Compostela. Departamento de Fisioloxíagl
dc.contributor.authorBeiroa Tarrío, Daniel
dc.contributor.authorRomero Picó, Amparo
dc.contributor.authorLanga, Carmen
dc.contributor.authorBernabeu, Carmelo
dc.contributor.authorLópez Pérez, Miguel A.
dc.contributor.authorLópez Novoa, José M.
dc.contributor.authorNogueiras Pozo, Rubén
dc.contributor.authorDiéguez González, Carlos
dc.date.accessioned2020-05-01T07:53:25Z
dc.date.available2020-05-01T07:53:25Z
dc.date.issued2013
dc.description.abstractEndoglin is a transmembrane auxiliary receptor for transforming growth factor-beta (TGF-beta) that is predominantly expressed on proliferating endothelial cells. It plays a wide range of physiological roles but its importance on energy balance or insulin sensitivity has been unexplored. Endoglin deficient mice die during midgestation due to cardiovascular defects. Here we report for first time that heterozygous endoglin deficiency in mice decreases high fat diet-induced hepatic triglyceride content and insulin levels. Importantly, these effects are independent of changes in body weight or adiposity. At molecular level, we failed to detect relevant changes in the insulin signalling pathway at basal levels in liver, muscle or adipose tissues that could explain the insulin-dependent effect. However, we found decreased triglyceride content in the liver of endoglin heterozygous mice fed a high fat diet in comparison to their wild type littermates. Overall, our findings indicate that endoglin is a potentially important physiological mediator of insulin levels and hepatic lipid metabolism.gl
dc.description.peerreviewedSIgl
dc.description.sponsorshipThis work has been supported by grants from Ministerio de Educacion y Ciencia (CD: BFU2011; ML: RyC-2007-00211; RN: RYC-2008-02219 and SAF2009-07049; GS: RYC-2009-04972, SAF2010-15881 and SAF2010-19347; JML-N: SAF2010-15881; CB: SAF2010-61827), Xunta de Galicia (ML: 10PXIB208164PR and RN: 2010/14), Junta de Castilla y León (Excellence Group GR100) Fondo Investigationes Sanitarias (ML: PS09/01880), Centro de Investigación Biomédica en Red (CIBER) de Fisiopatología de la Obesidad y Nutrición (CIBERobn), CIBER de Enfermedades Raras (CIBERER) and Red de Investigación Cooperativa en Enfermedades Renales (REDinREN). CIBERobn, CIBERER and RETIC REDinREN are initiatives of the Instituto de Salud Carlos III (ISCIII) of Spain supported by FEDER funds. The research leading to these results has also received funding from the European Community's Seventh Framework Programme under grant agreements (CD, ML and RN: FP7/2007-2013: n° 245009: NeuroFAST, and RN: ERC-2011-StG-OBESITY53-281408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.gl
dc.identifier.citationBeiroa D, Romero-Picó A, Langa C, Bernabeu C, López M, López-Novoa JM, et al. (2013) Heterozygous Deficiency of Endoglin Decreases Insulin and Hepatic Triglyceride Levels during High Fat Diet. PLoS ONE 8(1): e54591. https://doi.org/10.1371/journal.pone.0054591gl
dc.identifier.doi10.1371/journal.pone.0054591
dc.identifier.essn1932-6203
dc.identifier.urihttp://hdl.handle.net/10347/21951
dc.language.isoenggl
dc.publisherPLOSgl
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/245009
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/FP7/281408
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/RYC-2008-02219/ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MEC/Plan Nacional de I+D+i 2004-2007/RYC-2007-00211/ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/SAF2009-07049/ES/Papel De Los Receptores Opioides En La Regulacion Neuroendocrina De La Ingesta Y La Homeostasis De La Masa Corporal
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/RYC-2009-04972/ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/SAF2010-15881/ES/PAPEL DE LAS FORMAS CORTA Y SOLUBLE DE ENDOGLINA EN LA HOMEOSTASIS VASCULAR
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/ SAF2010-19347/ES/PAPEL DE LA OBESIDAD EN EL DESARROLLO DEL CANCER HEPATICO
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/SAF2010-61827/ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/MICINN/Plan Nacional de I+D+i 2008-2011/BFU2008-02001/ES/EFECTOS NEUROENDOCRINOS DE GHRELIN
dc.relation.publisherversionhttps://doi.org/10.1371/journal.pone.0054591gl
dc.rights© 2013 Beiroa et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are creditedgl
dc.rights.accessRightsopen accessgl
dc.rights.urihttps://creativecommons.org/licenses/by/3.0/
dc.titleHeterozygous deficiency of endoglin decreases insulin and hepatic triglyceride levels during high fat dietgl
dc.typejournal articlegl
dc.type.hasVersionVoRgl
dspace.entity.typePublication
relation.isAuthorOfPublicationfe6af4cf-b6e2-49b2-a988-f647d5091171
relation.isAuthorOfPublication65efc211-9a43-4312-8e7f-88b812cf2ae1
relation.isAuthorOfPublication5e85852a-86da-4c51-a990-34cc008a3ae7
relation.isAuthorOfPublication.latestForDiscovery65efc211-9a43-4312-8e7f-88b812cf2ae1

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
2013_plosone_beiroa_heterozygous.PDF
Size:
806.32 KB
Format:
Adobe Portable Document Format
Description: